Literature DB >> 19008402

A short amino acid sequence containing tyrosine in the N-terminal region of G protein-coupled receptors is critical for their potential use as co-receptors for human and simian immunodeficiency viruses.

Nobuaki Shimizu1, Atsushi Tanaka2,1, Atsushi Oue2,1, Takahisa Mori2,1, Chatchawann Apichartpiyakul3, Hiroo Hoshino2,1.   

Abstract

Various G protein-coupled receptors (GPCRs) have the potential to work as co-receptors for human and simian immunodeficiency virus (HIV/SIV). HIV/SIV co-receptors have several tyrosines in their extracellular N-terminal region (NTR) as a common feature. However, the domain structure of the NTR that is critical for GPCRs to have co-receptor activity has not been identified. Comparative studies of different HIV/SIV co-receptors are an effective way to clarify the domain. These studies have been carried out only for the major co-receptors, CCR5 and CXCR4. A chemokine receptor, D6, has been shown to mediate infection of astrocytes with HIV-1. Recently, it was also found that an orphan GPCR, GPR1, and a formyl peptide receptor, FPRL1, work as potent HIV/SIV co-receptors in addition to CCR5 and CXCR4. To elucidate more about the domain of the NTR critical for HIV/SIV co-receptor activity, this study analysed the effects of mutations in the NTR on the co-receptor activity of D6, FPRL1 and GPR1 in addition to CCR5. The results identified a number of tyrosines that are indispensable for the activity of these co-receptors. The number and positions of those tyrosines varied among co-receptors and among HIV-1 strains. Moreover, it was found that a small domain of a few amino acids containing a tyrosine is critical for the co-receptor activity of GPR1. These findings will be useful in elucidating the mechanism that allows GPCRs to have the potential to act as HIV/SIV co-receptors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19008402     DOI: 10.1099/vir.0.2008/002188-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  3 in total

1.  Virus entry via the alternative coreceptors CCR3 and FPRL1 differs by human immunodeficiency virus type 1 subtype.

Authors:  R Nedellec; M Coetzer; N Shimizu; H Hoshino; V R Polonis; L Morris; U E A Mårtensson; J Binley; J Overbaugh; D E Mosier
Journal:  J Virol       Date:  2009-06-24       Impact factor: 5.103

2.  CCR5 susceptibility to ligand-mediated down-modulation differs between human T lymphocytes and myeloid cells.

Authors:  James M Fox; Richard Kasprowicz; Oliver Hartley; Nathalie Signoret
Journal:  J Leukoc Biol       Date:  2015-05-08       Impact factor: 4.962

3.  CCR6 functions as a new coreceptor for limited primary human and simian immunodeficiency viruses.

Authors:  Salequl Islam; Nobuaki Shimizu; Sheikh Ariful Hoque; Atsushi Jinno-Oue; Atsushi Tanaka; Hiroo Hoshino
Journal:  PLoS One       Date:  2013-08-29       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.